Ultrasonographic Assessment of Muscle Morphology, Function, and Clinical Findings in Spastic Cerebral Palsy
Evaluation of the Relationship Between Ultrasonographic Muscle Morphology, Functional Properties, and Clinical Parameters in Children With Spastic Cerebral Palsy
Kocaeli University
36 participants
Dec 15, 2025
OBSERVATIONAL
Conditions
Summary
This study focuses on children with spastic cerebral palsy and aims to examine how muscle morphology and tissue characteristics, as assessed by ultrasound, may relate to functional motor abilities. It is designed as a prospective, cross-sectional, observational study. Planned ultrasound-based assessments include parameters such as muscle thickness, pennation angle, fascicle length, echo intensity, tissue stiffness (via shear wave elastography), and microvascular flow (via superb microvascular imaging). These measurements are intended to be compared with standard clinical evaluations, including the GMFCS, GMFM-66, MAS, MACS, and Tardieu Scale. The study seeks to contribute to a better understanding of the relationship between muscle architecture and functional outcomes, with the goal of generating insights that may inform individualized rehabilitation planning.
Eligibility
Inclusion Criteria4
- Diagnosis of spastic cerebral palsy (SCP) according to the criteria defined by Rosenbaum et al. (2007)
- Age between 4 and 18 years
- Gross Motor Function Classification System (GMFCS) Level I, II, or III
- Manual Ability Classification System (MACS) Level I, II, III, or IV
Exclusion Criteria8
- Non-spastic types of cerebral palsy (e.g., dyskinetic, ataxic)
- Diagnosis of neuromuscular disorders other than cerebral palsy (e.g., hereditary neuropathy, myopathy)
- Presence of muscle contractures or fixed deformities in the limbs selected for ultrasound and clinical assessment
- Cognitive or behavioral impairments that prevent cooperation during ultrasound or clinical evaluation
- Botulinum toxin-A (BoNT-A) injection applied to the target muscles within the last 6 months
- Current treatment with oral or intrathecal antispastic medications
- History of orthopedic surgery or selective dorsal rhizotomy involving the target muscles
- Acute infection, febrile illness, or severe systemic disease (e.g., advanced heart failure, respiratory insufficiency) that may compromise the safety of assessments
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07118228